Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy

Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy

We report a case of successful neoadjuvant four-drug combination therapy to avoid total pneumonectomy. A 33-year-old male patient was diagnosed with locally advanced non-squamous NSCLC harboring EGFR mutation in the left lower lobe. The patient experienced significant clinical downstaging after two...

Full description

Bibliographic Details
Main Authors: Jingpei Li, Ke Xu, Weipeng Cai, Yalei Zhang, Xin Zeng, Fei Cui, Zhexue Hao, Jun Liu, Jianxing He
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
neoadjuvant
EGFR mutation
targeted (selective) treatment
chemothearpy
surgery
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01145/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01145/full

Similar Items